P300-2013 Screening compound: N-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide

P300-2013 Screening compound: N-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide
P300-2013 Screening compound: N-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P300-2013
N-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P300-2013

Molecular Formula

C24H16F2N4O2 (C24 H16 F2 N4 O2)

Compound Name

N-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-7-carboxamide

IUPAC name

N-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-4-oxo-4H5H-pyrazolo[15-a]quinoxaline-7-carboxamide

SMILES

O=C(c(cc1)cc(N2Cc(cc3)ccc3F)c1-n1nccc1C2=O)Nc(cc1)ccc1F

InChI

InChI=1S/C24H16F2N4O2/c25-17-4-1-15(2-5-17)14-29-22-13-16(23(31)28-19-8-6-18(26)7-9-19)3-10-20(22)30-21(24(29)32)11-12-27-30/h1-13H,14H2,(H,28,31)

InChI Key

CUWFTVCGCLCHLF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29025564

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.41

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.949

Distribution Coefficient, logD

3.948

Water Solubility, LogSw

-4.22

Polar Surface Area

50.930

Acid Dissociation Constant (pKa)

9.89

Base Dissociation Constant (pKb)

0.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

4.20

P300-2013 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with P300-2013 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P300-2013?
Check Price and Availability of P300-2013, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P300-2013 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P300-2013
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P300-2013
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P300-2013 available by request